Abiopharma

New Form 4 - BIOCRYST PHARMACEUTICALS INC Filed: 2025-07-28 AccNo: 0001127602-25-019632 Size: 7 KB

New Form 144 - Enliven Therapeutics, Inc. Filed: 2025-07-28 AccNo: 0001974158-25-000048 Size: 7 KB

New Form 8-K - CervoMed Inc. Filed: 2025-07-28 AccNo: 0001437749-25-023646 Size: 225 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - EKSO BIONICS HOLDINGS, INC. Filed: 2025-07-28 AccNo: 0001437749-25-023643 Size: 284 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - Cyclacel Pharmaceuticals, Inc. Filed: 2025-07-28 AccNo: 0001641172-25-021159 Size: 406 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits

New Form 144 - Pennant Group, Inc. Filed: 2025-07-28 AccNo: 0001959173-25-004780 Size: 4 KB

New Form 4 - AGENUS INC Filed: 2025-07-28 AccNo: 0000950170-25-099156 Size: 7 KB

New Form 6-K - XTL BIOPHARMACEUTICALS LTD Filed: 2025-07-28 AccNo: 0001213900-25-068203 Size: 14 KB

New Form PRE 14A - ARTELO BIOSCIENCES, INC. Filed: 2025-07-28 AccNo: 0001640334-25-001329 Size: 1 MB

New Form 144 - Edwards Lifesciences Corp Filed: 2025-07-28 AccNo: 0001921094-25-000829 Size: 5 KB